Postnatal and long-term outcomes after in utero exposure to RAAS inhibitors: cohort study based on German claims data
Risk of fetopathy is higher after fetal exposure to ARBs than to angiotensin-converting enzyme inhibitors. In a small proportion of children, sequelae of fetal RAAS-I exposure might only manifest in the years following birth.
Authors
- Ulrike Haug (ORCID: https://orcid.org/0000-0002-1886-2923)
- Malte Braitmaier (ORCID: https://orcid.org/0000-0001-7534-4068)
- Kathrin Thöne (ORCID: https://orcid.org/0000-0002-3114-8273)
- Katarina Dathe (ORCID: https://orcid.org/0000-0002-8674-5817)
- Marlies Onken (ORCID: https://orcid.org/0000-0002-4385-612X)
- Christof Schaefer
Institutions
- University of Bremen (DE)
- Humboldt-Universität zu Berlin (DE)
- Techniker Krankenkasse (Germany) (DE)
- Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
Publication Details
- Journal
- Pediatric Nephrology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1007/s00467-025-07101-9
- Primary Topic
- Birth, Development, and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gemeinsame Bundesausschuss
- DAK-Gesundheit